Interviews

Cecilia Ma

2025-04-10

For us, an impact unicorn is a company where there is a direct relationship between the revenue it generates and the impact it creates. It is not just about doing no harm or contributing some good; the core business model ensures that for every dollar earned, there is a corresponding positive impact. If the company succeeds, it is creating significant value for society.

Abdulkader Rahmo

Co-Founder, President & CEO

SMSbiotech

2025-04-09

SMSbiotech is a biotech company based in California, specializing in regenerative medicine through the discovery and development of a novel human stem cell known as the Small Mobile Stem (SMS) cell.

Prof. Edith Heard

Director General

European Molecular Biology Laboratory (EMBL)

2025-04-09

The European Molecular Biology Laboratory (EMBL) is an intergovernmental research organization that conducts cutting-edge scientific research in molecular biology, provides services and infrastructure, trains scientists, and fosters collaboration across Europe to address global challenges in health and the environment.

Juan Francisco Politi, & Néstor De Cesare

VP & President

Allaria Fondos

2025-04-09

Argentina needs to improve productivity and show the world that a certain policy direction will stick through time. The government has managed a first batch of reform even in a minority, but more profound sustainable change requires political compromise and wider social consensus.

Dr. Ryan Saadi

Founder & CEO

Tevogen Bio

2025-04-08

Tevogen Bio is a clinical-stage specialty immunotherapy company developing off-the-shelf, precision T cell therapies for infectious diseases, cancers, and neurological disorders.

Stefan König

CEO

Merz Therapeutics

2025-04-08

Merz Therapeutics is a pharmaceutical company specializing in the development and commercialization of treatments in the areas of specialty neurology and movement disorders.

Alessandro Maselli

President & CEO

Catalent

2025-04-08

Catalent is a global leader in providing advanced drug development, delivery, and manufacturing solutions as a Contract Development and Manufacturing Organization (CDMO), specializing in biologics, gene therapies, and other innovative modalities.

Dr. Emil Kakkis

Founder, President & CEO

Ultragenyx

2025-04-08

Our approach involves using a viral vector to carry the gene for the missing enzyme into the bloodstream, which then crosses the blood-brain barrier and reaches nerve cells.

Dr. Martin Langer

CEO

BRAIN Biotech

2025-04-07

BRAIN Biotech is a German biotechnology company specializing in enzyme discovery, biocatalysis, and microbial strain development for industrial applications in pharmaceuticals, food, and sustainability.

Umang Vohra and Marc Falkin

Managing Director & Global CEO and CEO

Cipla, and Cipla North America

2025-04-07

Cipla is a global pharmaceutical company focused on providing high-quality medicines and innovative healthcare solutions, driven by its mission of "Caring for Life."

Pagina 16 din 175